BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu J, Wang J, Ling D. Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma. Small 2018;14. [PMID: 29251419 DOI: 10.1002/smll.201702037] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou C, Xia Y, Wei Y, Cheng L, Wei J, Guo B, Meng F, Cao S, van Hest JC, Zhong Z. GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma. Acta Biomaterialia 2020;113:512-21. [DOI: 10.1016/j.actbio.2020.06.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
2 Mahadevan G, Valiyaveettil S. Understanding the interactions of poly(methyl methacrylate) and poly(vinyl chloride) nanoparticles with BHK-21 cell line. Sci Rep 2021;11:2089. [PMID: 33483569 DOI: 10.1038/s41598-020-80708-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Farshbaf M, Khosroushahi AY, Mojarad-jabali S, Zarebkohan A, Valizadeh H, Walker PR. Cell surface GRP78: An emerging imaging marker and therapeutic target for cancer. Journal of Controlled Release 2020;328:932-41. [DOI: 10.1016/j.jconrel.2020.10.055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhao X, Liu X, Zhang P, Liu Y, Ran W, Cai Y, Wang J, Zhai Y, Wang G, Ding Y, Li Y. Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma. Acta Pharm Sin B 2019;9:1050-60. [PMID: 31649853 DOI: 10.1016/j.apsb.2019.06.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
5 Chen X, Zhang X, Zhang L, Gao Y, Wang C, Hong W, Zhao G, Li L, Liu R, Wang C. Amphiphilic Janus nanoparticles for imaging-guided synergistic chemo-photothermal hepatocellular carcinoma therapy in the second near-infrared window. Nanoscale 2021;13:3974-82. [PMID: 33595029 DOI: 10.1039/d0nr09017d] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yu L, Wang Z, Mo Z, Zou B, Yang Y, Sun R, Ma W, Yu M, Zhang S, Yu Z. Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy. Acta Pharm Sin B 2021;11:2004-15. [PMID: 34386334 DOI: 10.1016/j.apsb.2021.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zhang H, Deng L, Liu H, Mai S, Cheng Z, Shi G, Zeng H, Wu Z. Enhanced fluorescence/magnetic resonance dual imaging and gene therapy of liver cancer using cationized amylose nanoprobe. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100220] [Reference Citation Analysis]
8 Santo D, Mendonça PV, Lima MS, Cordeiro RA, Cabanas L, Serra A, Coelho JFJ, Faneca H. Poly(ethylene glycol)- block-poly(2-aminoethyl methacrylate hydrochloride)-Based Polyplexes as Serum-Tolerant Nanosystems for Enhanced Gene Delivery. Mol Pharm 2019;16:2129-41. [PMID: 30986077 DOI: 10.1021/acs.molpharmaceut.9b00101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
9 Chi X, Liu K, Luo X, Yin Z, Lin H, Gao J. Recent advances of nanomedicines for liver cancer therapy. J Mater Chem B 2020;8:3747-71. [DOI: 10.1039/c9tb02871d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Jia M, Zhang H, Qin Q, Hou Y, Zhang X, Chen D, Zhang H, Chen Y. Ferroptosis as a new therapeutic opportunity for nonviral liver disease. Eur J Pharmacol 2021;908:174319. [PMID: 34252441 DOI: 10.1016/j.ejphar.2021.174319] [Reference Citation Analysis]
11 Li J, Wu Y, Wang D, Zou L, Fu C, Zhang J, Leung GP. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects. Pharmacol Res 2019;146:104313. [PMID: 31202781 DOI: 10.1016/j.phrs.2019.104313] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
12 Jiang B, Zhang R, Zhang J, Hou Y, Chen X, Zhou M, Tian X, Hao C, Fan K, Yan X. GRP78-targeted ferritin nanocaged ultra-high dose of doxorubicin for hepatocellular carcinoma therapy. Theranostics 2019;9:2167-82. [PMID: 31149036 DOI: 10.7150/thno.30867] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
13 He K, Zhu J, Gong L, Tan Y, Chen H, Liang H, Huang B, Liu J. In situ self-assembly of near-infrared-emitting gold nanoparticles into body-clearable 1D nanostructures with rapid lysosome escape and fast cellular excretion. Nano Res 2021;14:1087-94. [DOI: 10.1007/s12274-020-3153-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
14 Chen Y, Fu Y, Li X, Chen H, Wang Z, Zhang H. Peptide-functionalized NaGdF 4 nanoparticles for tumor-targeted magnetic resonance imaging and effective therapy. RSC Adv 2019;9:17093-100. [DOI: 10.1039/c9ra02135c] [Cited by in Crossref: 9] [Article Influence: 3.0] [Reference Citation Analysis]
15 Xu S, Ling S, Shan Q, Ye Q, Zhan Q, Jiang G, Zhuo J, Pan B, Wen X, Feng T, Lu H, Wei X, Xie H, Zheng S, Xiang J, Shen Y, Xu X. Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma Therapy. Adv Sci (Weinh) 2021;8:2003042. [PMID: 33717848 DOI: 10.1002/advs.202003042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhang Y, Eltayeb O, Meng Y, Zhang G, Zhang Y, Shuang S, Dong C. Tumor microenvironment responsive mesoporous silica nanoparticles for dual delivery of doxorubicin and chemodynamic therapy (CDT) agent. New J Chem 2020;44:2578-86. [DOI: 10.1039/c9nj05427h] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
17 Chen X, Zhang X, Li S, Zhang L, Zhang Q, Chen Z, Li L, Su Z, Cheng S, Wang C. Engineering of Yin Yang-like nanocarriers for varisized guest delivery and synergistic eradication of patient-derived hepatocellular carcinoma. Nanoscale Horiz 2019;4:1046-55. [DOI: 10.1039/c8nh00467f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
18 Xin F, Wu M, Cai Z, Zhang X, Wei Z, Liu X, Liu J. Tumor Microenvironment Triggered Cascade-Activation Nanoplatform for Synergistic and Precise Treatment of Hepatocellular Carcinoma. Adv Healthc Mater 2021;10:e2002036. [PMID: 33644987 DOI: 10.1002/adhm.202002036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Chen H, Zhang H, Xu T, Yu J. An Overview of Micronanoswarms for Biomedical Applications. ACS Nano 2021;15:15625-44. [PMID: 34647455 DOI: 10.1021/acsnano.1c07363] [Reference Citation Analysis]
20 Wu Y, Xu Z, Sun W, Yang Y, Jin H, Qiu L, Chen J, Chen J. Co-responsive smart cyclodextrin-gated mesoporous silica nanoparticles with ligand-receptor engagement for anti-cancer treatment. Mater Sci Eng C Mater Biol Appl 2019;103:109831. [PMID: 31349481 DOI: 10.1016/j.msec.2019.109831] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
21 Gong L, Chen Y, He K, Liu J. Surface Coverage-Regulated Cellular Interaction of Ultrasmall Luminescent Gold Nanoparticles. ACS Nano 2019. [DOI: 10.1021/acsnano.8b08103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
22 Chew SA, Moscato S, George S, Azimi B, Danti S. Liver Cancer: Current and Future Trends Using Biomaterials. Cancers (Basel) 2019;11:E2026. [PMID: 31888198 DOI: 10.3390/cancers11122026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
23 Li Y, Xin F, Hu J, Jagdale S, Davis TP, Hagemeyer CE, Qiao R. Functionalization of NaGdF 4 nanoparticles with a dibromomaleimide-terminated polymer for MR/optical imaging of thrombosis. Polym Chem 2020;11:1010-7. [DOI: 10.1039/c9py01568j] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Luo G, Zhang J, Sun Y, Wang Y, Wang H, Cheng B, Shu Q, Fang X. Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis. Nanomicro Lett 2021;13:88. [PMID: 34138348 DOI: 10.1007/s40820-021-00598-3] [Reference Citation Analysis]
25 Chen Y, Li Y, Liu J, Zhu Q, Ma J, Zhu X. Erythrocyte membrane bioengineered nanoprobes via indocyanine green-directed assembly for single NIR laser-induced efficient photodynamic/photothermal theranostics. J Control Release 2021;335:345-58. [PMID: 34029633 DOI: 10.1016/j.jconrel.2021.05.025] [Reference Citation Analysis]
26 Vauthier C. A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles. J Drug Target 2019;27:502-24. [PMID: 30889991 DOI: 10.1080/1061186X.2019.1588280] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Cutrona MB, Simpson JC. A High-Throughput Automated Confocal Microscopy Platform for Quantitative Phenotyping of Nanoparticle Uptake and Transport in Spheroids. Small 2019;15:e1902033. [PMID: 31334922 DOI: 10.1002/smll.201902033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
28 Tao Y, Wang J, Xu X. Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances. Front Bioeng Biotechnol 2020;8:184. [PMID: 32211399 DOI: 10.3389/fbioe.2020.00184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Luo J, Gong T, Ma L. Chondroitin-modified lipid nanoparticles target the Golgi to degrade extracellular matrix for liver cancer management. Carbohydr Polym 2020;249:116887. [PMID: 32933700 DOI: 10.1016/j.carbpol.2020.116887] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
30 Escudero A, Carrillo-carrión C, Castillejos MC, Romero-ben E, Rosales-barrios C, Khiar N. Photodynamic therapy: photosensitizers and nanostructures. Mater Chem Front 2021;5:3788-812. [DOI: 10.1039/d0qm00922a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
31 Li Y, Lin J, Wang P, Luo Q, Zhu F, Zhang Y, Hou Z, Liu X, Liu J. Tumor Microenvironment Cascade-Responsive Nanodrug with Self-Targeting Activation and ROS Regeneration for Synergistic Oxidation-Chemotherapy. Nanomicro Lett 2020;12:182. [PMID: 34138172 DOI: 10.1007/s40820-020-00492-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
32 Zheleznyak A, Shokeen M, Achilefu S. Nanotherapeutics for multiple myeloma. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2018;10:e1526. [PMID: 29701006 DOI: 10.1002/wnan.1526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Liu S, Deng S, Li X, Cheng D. Size- and Surface- Dual Engineered Small Polyplexes for Efficiently Targeting Delivery of siRNA. Molecules 2021;26:3238. [PMID: 34072265 DOI: 10.3390/molecules26113238] [Reference Citation Analysis]
34 Luo X, Liu J. Ultrasmall Luminescent Metal Nanoparticles: Surface Engineering Strategies for Biological Targeting and Imaging. Adv Sci (Weinh) 2021;:e2103971. [PMID: 34796699 DOI: 10.1002/advs.202103971] [Reference Citation Analysis]
35 Elnaggar MH, Abushouk AI, Hassan AHE, Lamloum HM, Benmelouka A, Moatamed SA, Abd-Elmegeed H, Attia S, Samir A, Amr N, Johar D, Zaky S. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. Semin Cancer Biol 2021;69:91-9. [PMID: 31421265 DOI: 10.1016/j.semcancer.2019.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
36 Wang H, Ellipilli S, Lee WJ, Li X, Vieweger M, Ho YS, Guo P. Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance. J Control Release 2021;330:173-84. [PMID: 33316298 DOI: 10.1016/j.jconrel.2020.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
37 Du Z, Mao Y, Zhang P, Hu J, Fu J, You Q, Yin J. TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma. ACS Appl Mater Interfaces 2021;13:35518-32. [PMID: 34286569 DOI: 10.1021/acsami.1c09610] [Reference Citation Analysis]
38 Wong XY, Sena-torralba A, Álvarez-diduk R, Muthoosamy K, Merkoçi A. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs. ACS Nano 2020;14:2585-627. [DOI: 10.1021/acsnano.9b08133] [Cited by in Crossref: 75] [Cited by in F6Publishing: 54] [Article Influence: 37.5] [Reference Citation Analysis]